Rankings
▼
Calendar
BHVN Q4 2019 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$135M
Net Income
-$149M
EPS (Diluted)
$-2.85
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$249M
Free Cash Flow
-$250M
Stock-Based Comp.
$45M
Balance Sheet
Total Assets
$344M
Total Liabilities
$352M
Stockholders' Equity
-$7M
Cash & Equivalents
$317M
← FY 2019
All Quarters
Q1 2020 →